Medication unavailable: local stock issue or Canadian shortage?

A Canadian question posted this week asked whether a medication missing from one pharmacy was truly in shortage. The distinction matters: a counter-level stock-out may be local, distribution-related or part of a manufacturer-reported shortage. Those situations do not have the same reach, and none is a reason to change treatment on your own.

A medication missing from your pharmacy is not automatically in national shortage. Confirm the exact product and stock status with the pharmacist before pursuing a refill change. (Read more)

Start by identifying exactly what is unavailable

Ask the pharmacist whether the issue affects the precise product, strength, format or several versions with the same active ingredient. One pharmacy may be out while stock remains elsewhere in the supply chain. Conversely, a reported shortage may affect one manufacturer or presentation without preventing every patient from receiving the medication. The product name and, when available, its Drug Identification Number (DIN) make the check more precise.

Use the national signal without overreading it

Health Canada defines a drug shortage as a manufacturer being unable to supply enough product to meet all Canadian orders on time. Manufacturers of certain drugs must report actual and anticipated shortages in the national registry. The registry is useful, but Health Canada notes that a listing does not always result in a patient-level impact. It therefore confirms neither your pharmacy’s inventory nor the right option for your circumstances.

Your pharmacist is the first point of contact

Health Canada recommends speaking first with a pharmacist or prescriber when a medication is unavailable. The pharmacist can check supply, explain the scope of the problem and assess options permitted for the product, province and patient record. In Ontario and Quebec, some adaptations, substitutions or continuity measures may fall within professional judgment and carry limits. An option that fits one person is not automatically appropriate for another.

Bring the right information to a refill review

If a new prescription or clinical review becomes necessary, gather the exact medication name, strength, format, current directions, doses remaining, expected refill date and the message from the pharmacy. Also note whether the pharmacy described a local delay, pending order or reported shortage. This gives the professional useful context without assuming that replacement or renewal will be appropriate.

What to avoid

Do not alter the dose, format, schedule or medication on your own. Do not buy from an unverified seller or build an excessive reserve: Health Canada notes that purchasing beyond what you need can reduce access for others. If the pharmacist raises another strength, brand, presentation or therapeutic option, ask how it would be used and who will follow up before acting.

When MedVibe’s refill service may fit

MedVibe’s prescription-refill service lets someone explain a need related to an existing prescription when that pathway fits the situation. A licensed clinician reviews the information and may ask follow-up questions. Starting this pathway does not mean that renewal, replacement or pharmacy stock will be possible. Depending on the medication, urgency, province and clinical assessment, the pharmacist, usual prescriber or in-person care may be more appropriate.

This guide does not confirm that any specific product is in shortage and recommends no replacement. Stock can change quickly; verify it with the pharmacy and check the official registry for the exact product. If you may face an interruption, promptly contact the pharmacist or prescriber instead of changing treatment on your own. For non-urgent nurse advice in Ontario or Quebec, call 811. For severe symptoms, rapid deterioration or an emergency, call 911 or go to an emergency department.